Rooney CM - Search Results

1

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N. Ghazi A, et al. Among authors: rooney cm. J Immunother. 2012 Feb-Mar;35(2):159-68. doi: 10.1097/CJI.0b013e318247642f. J Immunother. 2012. PMID: 22306904 Free PMC article.

2

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

3

Gene marking after bone marrow transplantation.

Brenner MK, Rill DR, Heslop HE, Rooney CM, Roberts WM, Li C, Nilson T, Krance RA. Brenner MK, et al. Among authors: rooney cm. Eur J Cancer. 1994;30A(8):1171-6. doi: 10.1016/0959-8049(94)90478-2. Eur J Cancer. 1994. PMID: 7654451 Review. No abstract available.

4

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2. Lancet. 1995. PMID: 7799740

5

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease.

Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Rooney CM, et al. Br J Haematol. 1995 Jan;89(1):98-103. doi: 10.1111/j.1365-2141.1995.tb08904.x. Br J Haematol. 1995. PMID: 7833284

6

Donor T cells to treat EBV-associated lymphoma.

Heslop HE, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. N Engl J Med. 1994 Sep 8;331(10):679-80. doi: 10.1056/NEJM199409083311017. N Engl J Med. 1994. PMID: 8052285 No abstract available.

7

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Nat Med. 1996 May;2(5):551-5. doi: 10.1038/nm0596-551. Nat Med. 1996. PMID: 8616714

8

Use of gene marking in bone marrow transplantation.

Heslop HE, Rooney CM, Rill DR, Krance RA, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Cancer Detect Prev. 1996;20(2):108-13. Cancer Detect Prev. 1996. PMID: 8706035

9

Gene-marking and haemopoietic stem-cell transplantation.

Heslop HE, Rooney CM, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Blood Rev. 1995 Dec;9(4):220-5. doi: 10.1016/s0268-960x(95)90013-6. Blood Rev. 1995. PMID: 8839397 Review.

10

Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity.

Rooney CM, Smith CA, Heslop HE. Rooney CM, et al. Mol Med Today. 1997 Jan;3(1):24-30. doi: 10.1016/S1357-4310(96)10054-X. Mol Med Today. 1997. PMID: 9021739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters